Resmed (RMD) Common Equity (2010 - 2026)
Resmed (RMD) reported Common Equity of $5.95 billion for fiscal Q1 2027 (quarter ended Sep 30, 2026), down 2.8% from $6.12 billion a year earlier and down 9.7% from the prior quarter.
Resmed (RMD) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2026 (ended Jun 30, 2026), Resmed posted Common Equity of $6.59 billion, up 10.3% from FY2025.
- Common Equity has increased for 11 consecutive fiscal years, with a five-year compound annual growth rate of 17.9% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $5.97 billion in FY2025 (+22.7%), $4.86 billion in FY2024 (+17.8%), $4.13 billion in FY2023 (+22.9%) and $3.36 billion in FY2022 (+16.5%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Common Equity since fiscal Q3 2025.
- Year over year, Common Equity gained in seven of the last eight quarters, with growth averaging 15.3%.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2024 (growth of 23.8%); the low point was fiscal Q1 2027 (a decline of 2.8%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $6.59 billion (Q4 2026), $6.49 billion (Q3 2026) and $6.32 billion (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 265.71 Bn | 242.23 Bn | 5.13 Bn | 54.77 Bn |
| 2 | Abbott Laboratories | 189.37 Bn | 163.23 Bn | 7.39 Bn | 51.62 Bn |
| 3 | Danaher | 164.78 Bn | 144.43 Bn | 3.84 Bn | 53.63 Bn |
| 4 | Intuitive Surgical | 157.85 Bn | 138.13 Bn | 2.08 Bn | 16.12 Bn |
| 5 | Medtronic | 129.66 Bn | 94.91 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 121.82 Bn | 108.01 Bn | 4.25 Bn | 23.46 Bn |
| 7 | Boston Scientific | 63.42 Bn | 58.86 Bn | 3.43 Bn | 25.87 Bn |
| 8 | Edwards Lifesciences | 59.49 Bn | 42.69 Bn | 1.35 Bn | 10.96 Bn |
| 9 | Becton Dickinson | 58.38 Bn | 55.53 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Resmed | 33.31 Bn | 27.76 Bn | 870.57 Mn | 5.95 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.95 Bn |
| Jun 30, 2026 | 6.59 Bn |
| Mar 31, 2026 | 6.49 Bn |
| Dec 31, 2025 | 6.32 Bn |
| Sep 30, 2025 | 6.12 Bn |
| Jun 30, 2025 | 5.97 Bn |
| Mar 31, 2025 | 5.55 Bn |
| Dec 31, 2024 | 5.25 Bn |
| Sep 30, 2024 | 5.20 Bn |
| Jun 30, 2024 | 4.86 Bn |
| Mar 31, 2024 | 4.63 Bn |
| Dec 31, 2023 | 4.48 Bn |
| Sep 30, 2023 | 4.25 Bn |
| Jun 30, 2023 | 4.13 Bn |
| Mar 31, 2023 | 3.93 Bn |
| Dec 31, 2022 | 3.74 Bn |
| Sep 30, 2022 | 3.43 Bn |
| Jun 30, 2022 | 3.36 Bn |
| Mar 31, 2022 | 3.28 Bn |
| Dec 31, 2021 | 3.15 Bn |
Resmed Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RMD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();